rs149964592

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_031220.4(PITPNM3):​c.699C>T​(p.Val233Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00895 in 1,614,006 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0069 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0092 ( 85 hom. )

Consequence

PITPNM3
NM_031220.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.70

Publications

4 publications found
Variant links:
Genes affected
PITPNM3 (HGNC:21043): (PITPNM family member 3) This gene encodes a member of a family of membrane-associated phosphatidylinositol transfer domain-containing proteins. The calcium-binding protein has phosphatidylinositol (PI) transfer activity and interacts with the protein tyrosine kinase PTK2B (also known as PYK2). The protein is homologous to a Drosophila protein that is implicated in the visual transduction pathway in flies. Mutations in this gene result in autosomal dominant cone dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
PITPNM3 Gene-Disease associations (from GenCC):
  • cone-rod dystrophy 5
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 17-6478625-G-A is Benign according to our data. Variant chr17-6478625-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261950.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.7 with no splicing effect.
BS2
High AC in GnomAd4 at 1052 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PITPNM3NM_031220.4 linkc.699C>T p.Val233Val synonymous_variant Exon 7 of 20 ENST00000262483.13 NP_112497.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PITPNM3ENST00000262483.13 linkc.699C>T p.Val233Val synonymous_variant Exon 7 of 20 1 NM_031220.4 ENSP00000262483.8
PITPNM3ENST00000572795.1 linkn.3205C>T non_coding_transcript_exon_variant Exon 1 of 14 1
PITPNM3ENST00000421306.7 linkc.591C>T p.Val197Val synonymous_variant Exon 6 of 19 2 ENSP00000407882.3

Frequencies

GnomAD3 genomes
AF:
0.00692
AC:
1053
AN:
152150
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00983
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.00778
AC:
1950
AN:
250582
AF XY:
0.00787
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.00848
Gnomad ASJ exome
AF:
0.0123
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00269
Gnomad NFE exome
AF:
0.0115
Gnomad OTH exome
AF:
0.0134
GnomAD4 exome
AF:
0.00916
AC:
13388
AN:
1461738
Hom.:
85
Cov.:
33
AF XY:
0.00900
AC XY:
6541
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.00140
AC:
47
AN:
33480
American (AMR)
AF:
0.00875
AC:
391
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0123
AC:
321
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00276
AC:
238
AN:
86240
European-Finnish (FIN)
AF:
0.00283
AC:
151
AN:
53370
Middle Eastern (MID)
AF:
0.0118
AC:
68
AN:
5768
European-Non Finnish (NFE)
AF:
0.0105
AC:
11668
AN:
1111954
Other (OTH)
AF:
0.00835
AC:
504
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
773
1545
2318
3090
3863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00691
AC:
1052
AN:
152268
Hom.:
2
Cov.:
32
AF XY:
0.00670
AC XY:
499
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41548
American (AMR)
AF:
0.0109
AC:
166
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
43
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.00283
AC:
30
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00983
AC:
669
AN:
68030
Other (OTH)
AF:
0.0147
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
55
110
165
220
275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00919
Hom.:
2
Bravo
AF:
0.00828
Asia WGS
AF:
0.00173
AC:
7
AN:
3478
EpiCase
AF:
0.0117
EpiControl
AF:
0.0132

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PITPNM3: BP4, BP7, BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Cone-rod dystrophy 5 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.16
DANN
Benign
0.75
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149964592; hg19: chr17-6381945; COSMIC: COSV52592846; API